Effects of Serum on In Vitro Susceptibility Testing of Echinocandins
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The effects of protein binding on the activities of caspofungin, anidulafungin, and micafungin were evaluated against Candida and Aspergillus species. Adding human serum sharply increased the MICs of micafungin and anidulafungin and modestly affected the MIC of caspofungin. The increase in MICs does not appear consistent with the rate of protein binding for the three compounds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quality Control Limits for Broth Microdilution Susceptibility Tests of Ten Antifungal Agents
Barry, A. L., Pfaller, M. A., Brown, S. D., Espinel-Ingroff, A., Ghannoum, M. A., Knapp, C., Rennie, R. P., Rex, J. H., & Rinaldi, M. G. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.9.3457-3459.2000 · Cited by 211
Self-citation
Cited by
Garcia-Effron, G., Lee, S., Park, S., Cleary, J. D., & Perlin, D. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00443-09 · Cited by 323
Mechanisms of echinocandin antifungal drug resistance
Perlin, D. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12831 · Cited by 313
Current Perspectives on Echinocandin Class Drugs
Perlin, D. S. (2011) · Future Microbiology · doi:10.2217/fmb.11.19 · Cited by 274
“[135–137].”
Garcia-Effron, G., Park, S., & Perlin, D. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01162-08 · Cited by 256
“As previously reported (30, 32, 53), serum neutralized most potency differences between drugs observed in vitro assays.”
BackgroundResultPfaller, M. A., Diekema, D. J., Ostrosky-Zeichner, L., Rex, J. H., Alexander, B. D., Andes, D., Brown, S. D., Chaturvedi, V., Ghannoum, M. A., Knapp, C. C., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00566-08 · Cited by 250
“In vitro, the agents bind to different human serum proteins and the in vitro impact of this binding varies by agent (40, 44), with caspofungin least affected.”
BackgroundSelf-citationIn Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species
Andes, D., Diekema, D. J., Pfaller, M. A., Bohrmuller, J., Marchillo, K., & Lepak, A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01584-09 · Cited by 226
Breakthrough invasive candidiasis in patients on micafungin.
Pfeiffer, C. D., Garcia-Effron, G., Zaas, A. K., Perfect, J. R., Perlin, D. S., & Alexander, B. D. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02390-09 · Cited by 196
“However, these differences in drug potency were neutralized and in vitro echinocandin crossresistance became apparent when the culture medium was mixed with 50% human serum, a finding which has been replicated elsewhere (34, 36).”
ResultShields, R. K., Nguyen, M. H., Press, E. G., Kwa, A. L., Cheng, S., Du, C., & Clancy, C. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00027-12 · Cited by 171
The eagle effect and antibiotic-induced persistence: two sides of the same coin?
Prasetyoputri, A., Jarrad, A. M., Cooper, M. A., & Blaskovich, M. A. T. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2018.10.007 · Cited by 101
Echinocandin Resistance, Susceptibility Testing and Prophylaxis: Implications for Patient Management
Perlin, D. S. (2014) · Drugs · doi:10.1007/s40265-014-0286-5 · Cited by 99
“Firstly, the echinocandin drugs are highly serum protein bound, which reduces their relative efficacy and shifts MICs upward [85–87].”
Shields, R. K., Nguyen, M. H., Du, C., Press, E., Cheng, S., & Clancy, C. J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00999-10 · Cited by 65
Moreno-Velásquez, S. D., Seidel, C., Juvvadi, P. R., Steinbach, W. J., & Read, N. D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00710-17 · Cited by 57
Arendrup, M. C., Rodriguez-Tudela, J.-L., Park, S., Garcia-Effron, G., Delmas, G., Cuenca-Estrella, M., Gomez-Lopez, A., & Perlin, D. S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01364-10 · Cited by 57
“Earlier studies demonstrated that the addition of human serum to MIC assay media neutralizes differences between the in vitro properties of the echinocandin drugs (24, 26, 38).”
BackgroundLaskaris, P., Atrouni, A., Calera, J. A., d'Enfert, C., Munier-Lehmann, H., Cavaillon, J.-M., Latgé, J.-P., & Ibrahim-Granet, O. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00324-16 · Cited by 37
Susceptibility of Pneumocystis to Echinocandins in Suspension and Biofilm Cultures
Cushion, M. T., & Collins, M. S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00017-11 · Cited by 38
“The inhibitory effect of serum has been attributed to protein binding of the compounds and subsequent inhibition of effect (26), but there is no general consensus regarding the mechanism.”
BackgroundMethodInfluentialKawai, A., Yamagishi, Y., & Mikamo, H. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.05.007 · Cited by 23
“Factors such as protein binding in human serum might also influence the MIC for MFG, since serum shifts the activity of MFG in in vitro susceptibility tests on Candida spp [27,28].”
BackgroundArastehfar, A., Daneshnia, F., Floyd, D. J., Jeffries, N. E., Salehi, M., Perlin, D. S., Ilkit, M., Lass-Flöerl, C., & Mansour, M. K. (2024) · mBio · doi:10.1128/mbio.00072-24 · Cited by 19
“We noted that the addition of serum to YPD-and MOPS-treated RPMI allowed reliable differentiation of low and high persisters, which has also been suggested for inclusion in routine antifungal susceptibility testing to better predict in vivo outcomes (29, 30).”
BackgroundJia, Y., Tang, R.-J., Wang, L., Zhang, X., Wang, Y., Jia, X.-M., & Jiang, Y.-Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048369 · Cited by 19
“Previous studies have demonstrated that biological fluids such as serum can have profound effects on antifungal susceptibilities [43,44,45,46].”
BackgroundDrug susceptibility of matrix‐encapsulated Candida albicans nano‐biofilms
Srinivasan, A., Gupta, C. M., Agrawal, C. M., Leung, K. P., Lopez‐Ribot, J. L., & Ramasubramanian, A. K. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25120 · Cited by 11
“compared to 0% serum in 96-well plate assays (Odabasi et al. 2007).”
Background
Metadata
- Authors
- Odabasi, Z., Paetznick, V., Rex, J. H., & Ostrosky-Zeichner, L.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2007-11
- Volume
- 51
- Issue
- 11
- Pages
- 4214-4216
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2116355036
- Cited by
- 69
- References
- 1
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.